MAPT and Alzheimer disease: However, in AD patients, underlying pathologies – including brain atrophy, amyloid-beta plaques, and tau tangles (Jack et al., 2013, Opitz et al., 2011, Pereira et al., 2021) – severely disrupt synaptic connections and network integrity, likely contributing to E-field characteristics contrasting with HCs.